Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Positron Corp. announced the sale and installation of its PET scanner to Manhattan based, Gramercy Cardiac Diagnostic Services, owned by New York City cardiologist.

Positron Corp., a molecular imaging solutions company focused on Nuclear Cardiology, announced the sale and installation of its PET scanner to Manhattan based, Gramercy Cardiac Diagnostic Services, owned by New York City cardiologist, Dr. Peter Rentrop.

Joseph Oliverio, Chief Technology Officer of Positron said, "Dr. Rentrop is a leader in the nuclear cardiology field and has been performing SPECT imaging in the greater New York City area for decades and we are proud that he selected Positron for his Cardiac PET imaging device." Oliverio further said, "Dr. Rentrop's addition of PET imaging to complement his SPECT business further validates cardiologist's move towards PET and the acceptance of the technology as the future of nuclear cardiology. Positron has the ideal solution for thousands of cardiology groups looking to improve their diagnostic accuracy at an affordable price."

Dr. Peter Rentrop added, "I am delighted with the opportunities that PET gives Gramercy Cardiac's partner physicians to extend and improve the services they provide to the patient communities of New York. The improved diagnostic accuracy of PET will prove invaluable in improving patient outcomes and I am glad to be partnering with Positron in this program."

Source: Positron Corp.

You can discuss about Positron Corp. and its products & services in the Positron Company User Group.

Discuss about PET and related topics in our PET Group.